MDA-MB-468 Cell Morphology, Biomiga

MDA-MB-468 (Human breast cancer cell line) Whole Cell Lysate, 100ug, Biomiga



In stock

MDA-MB-468 (Human breast cancer cell line) Whole Cell Lysate, Biomiga

Biomiga provides researchers with a variety of ready-to-use cell line lysates for proteomics research. Biomiga lysates are available for applications including electrophoresis, western blot, immunoprecipitation, enzymatic activity analysis, protein-protein interaction analysis, and tissue specific expression identification. Please check product documentation to see recommended and tested applications for each cell line lysate.


MDA-MB-468 (Human breast cancer cell line) Whole Cell Lysate

Tested applications 


Suggested applications 

WB, ELISA, Immunoprecipitation



Recommended dilutions

MDA-MB-468 cell lysate is ready to load on SDS-PAGE for Western blotting, 20 µg per lane is recommended for mini gel.


MDA-MB-468 cell lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylene diamine tetra acetic acid, 1 mM phenyl methyl sulfonyl flouride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecyl sulfate, 5 µg/ml of aprotinin, 5 µg/ml of leupeptin). Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay.


Whole Cell Lysate


It is supplied as whole cell lysate, in RIPA buffer with protease inhibitors and phosphotase inhibitors.


2.000 mg/ml

Storage instructions 

Shipped on dry ice. Upon delivery aliquot and store at  -80°C. Avoid repeated freeze / thaw cycles.


Cell line: MDA-MB-468 (Human breast adenocarcinoma)
Growth media: RPMI1640 & 10% FCS (Fetal Calf serum)

GAPDH western blot using MDA-MB-468 lysate.

No posts found